Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2002 Jun;87(6):535-43.
doi: 10.1136/heart.87.6.535.

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

G Nichol  1 , F McAlister, B Pham, A Laupacis, B Shea, M Green, A Tang, G Wells
Affiliations
Meta-Analysis

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

G Nichol et al. Heart. 2002 Jun.

Abstract

Objective: To conduct a meta-analysis of randomised controlled trials to estimate the effectiveness of antiarrhythmic drugs at promoting sinus rhythm in patients with atrial fibrillation.

Design: Articles were identified by using a comprehensive search of English language papers indexed in Medline from 1966 to August 2001. For the outcomes of sinus rhythm and death, a random effects model was used to model repeated assessments within a study at different time points.

Setting: Emergency departments and ambulatory clinics.

Patients: Patients with atrial fibrillation.

Interventions: Antiarrhythmic agents grouped according to their Vaughan-Williams class.

Main outcome measures: Sinus rhythm and mortality.

Results: 91 articles met a priori criteria for inclusion in the analysis. Median duration of follow up was one day (range 0.04-1096, mean (SD) 46 (136) days). The median proportion of patients in sinus rhythm at follow up was 55% (range 0-100%) and 32% (range 0-90%) receiving active treatment and placebo, respectively. Median survival was 99% (range 55-100%) and 99% (range 55-100%). Compared with placebo, the following drug classes were associated with increased sinus rhythm at follow up: IA (treatment difference 21.5%, 95% confidence interval (CI) 16.3% to 26.8%); IC (treatment difference 33.1%, 95% CI 23.3% to 42.9%); and III (treatment difference 17.4%, 95% CI 11.5% to 23.3%). Class IC drugs were associated with increased sinus rhythm at follow up compared with class IV drugs (treatment difference 43.2%, 95% CI 11.5% to 75.0%). There was no significant difference in mortality between any drug classes.

Conclusions: Class IA, IC, and III drugs are associated with increased sinus rhythm at follow up compared with placebo. It is unclear whether any antiarrhythmic drug class is associated with increased or decreased mortality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Absolute treatment difference in proportion of patients with normal sinus rhythm (%) at end of study between class IA drugs and placebo.
Figure 2
Figure 2
Absolute treatment difference in proportion of patients with normal sinus rhythm (%) at end of study between class IC agents and placebo.
Figure 3
Figure 3
Absolute treatment difference in proportion of patients with normal sinus rhythm (%) at end of study between class III agents and placebo.
See this image and copyright information in PMC

References

    1. Bailey D, Lehmann MH, Schumacher DN, et al. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 1992;19:41A.
    1. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann Intern Med 1992;116:1–5. - PubMed
    1. Kieny JR, Sacrez A, Facello A, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992;13:1290–5. - PubMed
    1. Kieny JR, Sacrez A, Facello A, et al. The causes of dilated cardiomyopathy: a clinical pathological review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586–90. - PubMed
    1. Sarembock IJ, Horak AR, Commerford PJ. Tachycardia-induced left ventricular dysfunction: a report of two cases. S Afr Med J 1988;73:484–5. - PubMed

Publication types

MeSH terms

Substances